OTC Drug Market in India 2011
Price: $600.00 (€456.51) ($720.00 (€547.82) Including VAT at 20%)
|
| Publication Date: Oct-2011
Pages: 42
Format: PDF
Publisher: Netscribes (India) Pvt. Ltd.
Sample Pages
Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position within the next five years. Since Indian patients have a huge tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign and domestic players. Rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, increasing focus on brand building, booming retail growth and changing demographics is helping the market to grow. The Indian Government, on its part has taken initiatives to reduce drug prices, has made certain reforms in the tax structure and has undertaken various other initiatives to promote the OTC market. The market is expected to exhibit steady growth over the next few years.
The report begins with the introduction section which offers a brief insight into the major over-the-counter segments. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. The top ten OTC brands in both the Indian and the global market, along with the sales figures have been provided. The report also provides individual market sizes for the different segments of the OTC market.
An analysis of the drivers explains the factors for growth of the industry including rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, booming retail growth, increasing focus on brand building, changing demographics and lower price control. The key challenges include low penetration in rural areas, preference of home remedies to OTC products, high competition and time consuming clinical trial procedures
The government initiatives section gives analyses the efforts to reduce drug prices, changes in the customs duty structure and the various other initiatives undertaken by the Government.
A brief overview of the drug market value chain and drug regulations is presented in the next section. It analyses the pharmaceutical value chain, and focuses on the different stages of clinical trial that a drug must pass through. A snapshot of different regulatory frameworks existing in the Indian pharma industry has been shown.
The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.
Table of Contents |
|
 |
|
|
OTC Pharmaceuticals: Global Industry Almanac
Price: $2,995.00 (€2,278.77) ($3,594.00 (€2,734.52) Including VAT at 20%)
|
| Publication Date: 01-Nov-2010
Please click here for more information or to purchase this report at our partner store
Datamonitor's OTC Pharmaceuticals: Global Industry Almanac: Global Industry Almanac is an essential resource for top-level data & analysis covering the OTC Pharmaceuticals industry. It includes data on market size & segmentation, textual analysis of the key trends & competitive landscape, & profiles of the leading companies. This incisive report provides expert analysis on a global, regional & country basis. |
|
|
OTC Opportunities in Europe, the US and Japan: Key trends, leading players and future Rx-OTC switching
Price: $3,835.00 (€2,917.89) ($4,602.00 (€3,501.46) Including VAT at 20%)
|
| Publication Date: 29-Jan-2010
Please click here for more information or to purchase this report at our partner store
This report provides a background on market dynamics (including overall market size and therapeutic category size) for each of the core countries under analysis. It also examines products and categories that are likely to be switched in the future, details regulatory changes that are predicted to impact the over-the-counter (OTC) market and provides growth forecasts to 2013. Included in the report are case studies for two of the most significant recent switches of recent years, Alli and Zocor. |
|
|
OTC Pharmaceuticals: Global Industry Guide 2010
Price: $1,495.00 (€1,137.48) ($1,794.00 (€1,364.98) Including VAT at 20%)
|
| Publication Date: 27-Apr-2010
Please click here for more information or to purchase this report at our partner store
Datamonitor's OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis. |
|
|
OTC Pharmaceuticals - Scandinavia Industry Guide 2010
Price: $795.00 (€604.88) ($954.00 (€725.86) Including VAT at 20%)
|
| Publication Date: 27-Apr-2010
Please click here for more information or to purchase this report at our partner store
Datamonitor's OTC Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas within the market. |
|
|
OTC Pharmaceuticals: Global Industry Almanac 2010
Price: $2,995.00 (€2,278.77) ($3,594.00 (€2,734.52) Including VAT at 20%)
|
| Publication Date: 27-Apr-2010
Please click here for more information or to purchase this report at our partner store
Datamonitor's OTC Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis. |
|
|
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide 2010
Price: $1,495.00 (€1,137.48) ($1,794.00 (€1,364.98) Including VAT at 20%)
|
| Publication Date: 31-Mar-2010
Please click here for more information or to purchase this report at our partner store
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market. |
|
|
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide 2010
Price: $995.00 (€757.05) ($1,194.00 (€908.46) Including VAT at 20%)
|
| Publication Date: 31-Mar-2010
Please click here for more information or to purchase this report at our partner store
Datamonitor's OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market. |
|
|
OTC Pharmaceuticals - North America (NAFTA) Industry Guide 2010
Price: $795.00 (€604.88) ($954.00 (€725.86) Including VAT at 20%)
|
| Publication Date: 31-Mar-2010
Please click here for more information or to purchase this report at our partner store
Datamonitor's OTC Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market. |
|
|
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide 2010
Price: $995.00 (€757.05) ($1,194.00 (€908.46) Including VAT at 20%)
|
| Publication Date: 31-Mar-2010
Please click here for more information or to purchase this report at our partner store
Datamonitor's OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Be alerted by email of new featured reports
Browse upcoming events or submit your own